Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.

Saved in:
Bibliographic Details
Title: Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.
Authors: Eyre, Toby A.1 toby.eyre@ouh.nhs.uk, Phillips, Elizabeth H.2, Linton, Kim M.3, Arumainathan, Arvind4, Kassam, Shireen5, Gibb, Adam3, Allibone, Suzanne3, Radford, John3, Peggs, Karl2, Burton, Cathy6, Stewart, Gillian6, LeDieu, Rifca7, Booth, Catherine7, Osborne, Wendy L.8, Miall, Fiona9, Eyre, David W.10, Ardeshna, Kirit M.2, Collins, Graham P.1
Source: British Journal of Haematology. Nov2017, Vol. 179 Issue 3, p471-479. 9p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00071048
DOI:10.1111/bjh.14898